Evans DL - Search Results

1

Dopaminergic and serotonergic activities of imidazoquinolinones and related compounds.

Moon MW, Morris JK, Heier RF, Chidester CG, Hoffmann WE, Piercey MF, Althaus JS, Von Voigtlander PF, Evans DL, Figur LM, et al. Moon MW, et al. Among authors: evans dl. J Med Chem. 1992 Mar 20;35(6):1076-92. doi: 10.1021/jm00084a013. J Med Chem. 1992. PMID: 1348089

2

Dopamine D2 receptor binding properties of [3H]U-86170, a dopamine receptor agonist.

Lahti RA, Evans DL, Figur LM, Carrigan KJ, Moon MW, Hsi RS. Lahti RA, et al. Among authors: evans dl. Eur J Pharmacol. 1991 Sep 17;202(2):289-91. doi: 10.1016/0014-2999(91)90308-d. Eur J Pharmacol. 1991. PMID: 1687034

3

Pre- and postsynaptic dopaminergic activities of U-86170F.

Lahti RA, Evans DL, Figur LM, Huff RM, Moon MW. Lahti RA, et al. Among authors: evans dl. Naunyn Schmiedebergs Arch Pharmacol. 1991 Nov;344(5):509-13. doi: 10.1007/BF00170644. Naunyn Schmiedebergs Arch Pharmacol. 1991. PMID: 1687420

4

Intrinsic activity of DA agonists.

Lahti RA, Figur LM, Piercey MF, Ruppel PL, Evans DL. Lahti RA, et al. Among authors: evans dl. Clin Neuropharmacol. 1992;15 Suppl 1 Pt A:182A-183A. doi: 10.1097/00002826-199201001-00096. Clin Neuropharmacol. 1992. PMID: 1354024 No abstract available.

5

Intrinsic activity determinations at the dopamine D2 guanine nucleotide-binding protein-coupled receptor: utilization of receptor state binding affinities.

Lahti RA, Figur LM, Piercey MF, Ruppel PL, Evans DL. Lahti RA, et al. Among authors: evans dl. Mol Pharmacol. 1992 Sep;42(3):432-8. Mol Pharmacol. 1992. PMID: 1357542

6

Rat brain binding sites for pramipexole, a clinically useful D3-preferring dopamine agonist.

Camacho-Ochoa M, Walker EL, Evans DL, Piercey MF. Camacho-Ochoa M, et al. Among authors: evans dl. Neurosci Lett. 1995 Aug 18;196(1-2):97-100. doi: 10.1016/0304-3940(95)11857-s. Neurosci Lett. 1995. PMID: 7501268

7

Induction of c-fos mRNA in rat medial prefrontal cortex by antipsychotic drugs: role of dopamine D2 and D3 receptors.

Merchant KM, Figur LM, Evans DL. Merchant KM, et al. Among authors: evans dl. Cereb Cortex. 1996 Jul-Aug;6(4):561-70. doi: 10.1093/cercor/6.4.561. Cereb Cortex. 1996. PMID: 8670682

8

Dopamine D4 versus D2 receptor selectivity of dopamine receptor antagonists: possible therapeutic implications.

Lahti RA, Evans DL, Stratman NC, Figur LM. Lahti RA, et al. Among authors: evans dl. Eur J Pharmacol. 1993 Jun 4;236(3):483-6. doi: 10.1016/0014-2999(93)90488-4. Eur J Pharmacol. 1993. PMID: 8102973

9

Growth of Chinese hamster ovary (CHO) cells expressing the 5-HT2 serotonin receptor in suspension culture: an efficient method for large-scale acquisition of membrane protein for drug evaluation.

Zaworski PG, Evans DL, Lahti RA, Gill GS. Zaworski PG, et al. Among authors: evans dl. J Neurosci Methods. 1995 Feb;56(2):169-75. doi: 10.1016/0165-0270(94)00119-2. J Neurosci Methods. 1995. PMID: 7752682

10

Comparison of pramipexole, fluoxetine, and placebo in patients with major depression.

Corrigan MH, Denahan AQ, Wright CE, Ragual RJ, Evans DL. Corrigan MH, et al. Among authors: evans dl. Depress Anxiety. 2000;11(2):58-65. doi: 10.1002/(sici)1520-6394(2000)11:2<58::aid-da2>3.0.co;2-h. Depress Anxiety. 2000. PMID: 10812530 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

439 results

Search Page

Filters